Macquarie’s Bhatia says a 10% market correction wouldn’t be a bad thing

Sandeep Bhatia, Managing Director and Head of Equity India at Macquarie Capital, highlights Sun Pharma as a preferred pick, citing its ability to deliver consistent earnings growth while still trading at relatively reasonable valuations compared to peers. He also maintains a positive outlook on names like Chalet Hotels and ITC Hotels.

Leave a Reply

Your email address will not be published. Required fields are marked *